hist162479Referred to the joint committee for review of Administrative Rules, February 14, 2023. Relating to scheduling Brorphine.
hist162477Referred to the joint committee for review of Administrative Rules, February 14, 2023. Relating to service fund for people who are deaf, deafblind or hard of hearing.
hist162475Referred to the joint committee for review of Administrative Rules, February 14, 2023. Relating to long-term care services and Medical Assistance fair hearing process.
hist162473Referred to the joint committee for review of Administrative Rules, February 14, 2023. Relating to scheduling Serdexmethylphenidate.
hist162471Referred to the joint committee for review of Administrative Rules, February 14, 2023. Relating to scheduling ten (10) fentanyl related substances.
hist162446Referred to the joint committee for review of Administrative Rules, February 14, 2023. Relating to scheduling Alfaxalone.
hist162444Referred to the joint committee for review of Administrative Rules, February 14, 2023. Relating to Excluding 6-beta-Naltrexol.
hist162442Referred to the joint committee for review of Administrative Rules, February 14, 2023. Relating to scheduling Fospropofol.
hist162440Referred to the joint committee for review of Administrative Rules, February 14, 2023. Relating to scheduling Embutramide.
hist162438Referred to the joint committee for review of Administrative Rules, February 14, 2023. Relating to scheduling Perampanel.
hist162436Referred to the joint committee for review of Administrative Rules, February 14, 2023. Relating to scheduling Lacosamide.
hist162434Referred to the joint committee for review of Administrative Rules, February 14, 2023. Relating to transferring 1-phenylcyclohexylamine and 1-piperidinocyclohexanecarbonitrile, immediate precursors to phencyclidine, also known as PCP.
hist162432Referred to the joint committee for review of Administrative Rules, February 14, 2023. Relating to telehealth.
hist162430Referred to the joint committee for review of Administrative Rules, February 14, 2023. Relating to SeniorCare Prescription Drugs.
hist162428Referred to the joint committee for review of Administrative Rules, February 14, 2023. Relating to 4,4’-Dimethylaminorex.
hist162426Referred to the joint committee for review of Administrative Rules, February 14, 2023. Relating to definitions.
hist162424Referred to the joint committee for review of Administrative Rules, February 14, 2023. RACHAEL CABRAL-GUEVARA
Chairperson
_____________
The committee on Labor, Regulatory Reform, Veterans and Military Affairs reported and recommended:
Relating to general updates.
hist162420Referred to the joint committee for review of Administrative Rules, February 14, 2023. Relating to the employment and entrepreneurship grants transition program.
hist162422Referred to the joint committee for review of Administrative Rules, February 14, 2023. PATRICK TESTIN
Chairperson
_____________
Advice and Consent of the Senate
State of Wisconsin
Office of the Governor
February 14, 2023
The Honorable, the Senate:
I am pleased to nominate and with the advice and consent of the Senate, do appoint JOAN M PRINCE, of Milwaukee, as a Congressional District 4 Representative on the Board of Regents of the University of Wisconsin System, to serve for the term ending May 1, 2023.
Respectfully Submitted,
TONY EVERS